Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment
Clinical trial NCT00845104 · WITHDRAWN
Trial details
- NCT number
- NCT00845104
- Sponsor
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.